Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Harvard University
Research
Fighting drug-resistant cancer by blocking an escape route
A new Science Signaling study pointed to a DNA damage response pathway that helps cancer cells escape destructions by chemo and radiotherapy.
Angus Liu
Jan 5, 2022 8:35am
Harvard's Nabla Bio nabs $11M for AI-driven antibody design
Dec 7, 2021 9:34am
Immunai adds $215M to bank to help discovery drug targets
Oct 27, 2021 12:00pm
Resilience commits $30M to form new biotechs out of Harvard labs
Oct 15, 2021 9:09am
Garuda bags $72M to advance off-the-shelf stem cell transplants
Sep 23, 2021 8:00am
Elevian snags $40M for stroke recovery trials in early 2023
Sep 17, 2021 8:30am